CrystalsFirst

We provide a variety of stand-alone packages for crystallographic fragment screening and co-structure determination addressing non-covalent, and covalent modalities as well as cryptic sites. Our mission is to provide the world‘s most advanced service platform to unlock chemical matter and help to bring the most innovative medicines to patients. We provide cutting-edge solutions to unlock chemical matter for protein targets. Gerhard Klebe, has become a recognized service provider in biotech and pharma. We offer top-notch drug discovery and high-performance structural biology services. We offer cutting-edge technology and experience to support with drug discovery projects across protein families and modalities. We also offer integrated drug research, from early drug discovery to preclinical development.